Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Events & presentations

09 Oct 2019

Future is now: Leaders in Ocular Gene Therapy Meeting, San Francisco (CA)

05 Sep 2019 - 08 Sep 2019

EURETINA 2019 Congress, Paris, France

26 Jul 2019 - 30 Jul 2019

2019 Annual Meeting ASRS, Chicago, IL (US)

26 Jun 2019 - 29 Jun 2019

UMDF Mitochondrial Medicine 2019, Washington DC, US

16 Jun 2019 - 19 Jun 2019

14th Meeting of EUNOS, Porto, Portugal

13 Jun 2019 - 16 Jun 2019

2019 SOE Congress, European Society of Ophthalmology, Nice, France

03 Jun 2019 - 06 Jun 2019

BIO International Convention, Philadelphia, PA (US)

23 May 2019

KOL Event to present Phase 3 REVERSE&RESCUE results of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON), New York City

28 Apr 2019 - 02 May 2019

ARVO Annual Meeting, Vancouver, BC, Canada

25 Mar 2019 - 27 Mar 2019

BioEurope Spring, Vienna, Austria

  • View previous 9 articles
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 17
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page